Open AccessConscientiousness is modified by genetic variation in catechol‐ O ‐methyltransferase to reduce symptom complaints in IBS patients
Author(s) -
Hall Kathryn T.,
Tolkin Benjamin R.,
Chinn Garrett M.,
Kirsch Irving,
Kelley John M.,
Lembo Anthony J.,
Kaptchuk Ted J.,
Kokkotou Efi,
Davis Roger B.,
Conboy Lisa A.
Publication year - 2015
Publication title -
brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.915
H-Index - 41
ISSN - 2162-3279
DOI - 10.1002/brb3.294
Subject(s) - conscientiousness , rs4680 , neuroticism , placebo , agreeableness , clinical psychology , personality , catechol o methyl transferase , context (archaeology) , irritable bowel syndrome , big five personality traits , medicine , anxiety , psychology , psychiatry , extraversion and introversion , genotype , social psychology , biochemistry , chemistry , paleontology , alternative medicine , pathology , biology , gene
Background Attention to and perception of physical sensations and somatic states can significantly influence reporting of complaints and symptoms in the context of clinical care and randomized trials. Although anxiety and high neuroticism are known to increase the frequency and severity of complaints, it is not known if other personality dimensions or genes associated with cognitive function or sympathetic tone can influence complaints. Genetic variation in catechol‐ O ‐methyltransferase ( COMT ) is associated with anxiety, personality, pain, and response to placebo treatment. We hypothesized that the association of complaint reporting with personality might be modified by variation in the COMT val158met genotype. Methods We administered a standard 25‐item complaint survey weekly over 3‐weeks to a convenience sample of 187 irritable bowel syndrome patients enrolled in a placebo intervention trial and conducted a repeated measures analysis. Results We found that complaint severity rating, our primary outcome, was negatively associated with the personality measures of conscientiousness (β = −0.31 SE 0.11, P = 0.003) and agreeableness (β = −0.38 SE 0.12, P = 0.002) and was positively associated with neuroticism (β = 0.24 SE 0.09, P = 0.005) and anxiety (β = 0.48 SE 0.09, P < 0.0001). We also found a significant interaction effect of COMT met alleles (β = −32.5 SE 14.1, P = 0.021). in patients genotyped for COMT val158met ( N = 87) specifically COMT × conscientiousness (β = 0.73 SE 0.26, P = 0.0042) and COMT × anxiety (β = −0.42 SE 0.16, P = 0.0078) interaction effects. Conclusion These findings potentially broaden our understanding of the factors underlying clinical complaints to include the personality dimension of conscientiousness and its modification by COMT .